Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Moshe Oren

Showing results (161-170 of 172) with videos related to

Pageof 18
Sort By:
Cell|August 28, 2018
Small Molecules Co-targeting CKIα and the Transcriptional Kinases CDK7/9 Control AML in Preclinical ModelsWaleed Minzel, Avanthika Venkatachalam, Avner Fink, et al.
Biorxiv : the Preprint Server for Biology|July 16, 2025
Sensitizing Immune-Refractory Ovarian Tumors via p53 Mutation-Tailored ImmunotherapyRishita Chatterjee, Arturo Simoni-Nieves, An Truong, et al.
Molecular Systems Biology|April 5, 2024
Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stabilityYiQing Lü, Tiffany Cho, Saptaparna Mukherjee, et al.
Clinical Epigenetics|April 29, 2026
GLYATL1 is associated with metabolic and epigenetic changes and with endocrine resistance in luminal breast cancerJanina Müller, Emre Sofyali, Luisa Schwarzmüller, et al.
Nature Metabolism|June 10, 2024
ASS1 metabolically contributes to the nuclear and cytosolic p53-mediated DNA damage responseLisha Qiu Jin Lim, Lital Adler, Emma Hajaj, et al.
Nature Metabolism|July 4, 2024
Author Correction: ASS1 metabolically contributes to the nuclear and cytosolic p53-mediated DNA damage responseLisha Qiu Jin Lim, Lital Adler, Emma Hajaj, et al.
Cancer Discovery|July 27, 2022
AXL and Error-Prone DNA Replication Confer Drug Resistance and Offer Strategies to Treat EGFR-Mutant Lung CancerAshish Noronha, Nishanth Belugali Nataraj, Joo Sang Lee, et al.
Cancer Cell|May 1, 2026
Activated T cell extracellular vesicle DNA transfer enhances antigen presentation and anti-tumor immunityMengying Hu, Di-Ao Liu, Inbal Wortzel, et al.
Nature Medicine|June 28, 2024
Multi-parametric atlas of the pre-metastatic liver for prediction of metastatic outcome in early-stage pancreatic cancerLinda Bojmar, Constantinos P Zambirinis, Jonathan M Hernandez, et al.
Cell|August 16, 2020
Extracellular Vesicle and Particle Biomarkers Define Multiple Human CancersAyuko Hoshino, Han Sang Kim, Linda Bojmar, et al.
Pageof 18

Showing results (161-170 of 172) with videos related to

Sort By:
Pageof 18
Cell|August 28, 2018
Small Molecules Co-targeting CKIα and the Transcriptional Kinases CDK7/9 Control AML in Preclinical ModelsWaleed Minzel, Avanthika Venkatachalam, Avner Fink, et al.
Biorxiv : the Preprint Server for Biology|July 16, 2025
Sensitizing Immune-Refractory Ovarian Tumors via p53 Mutation-Tailored ImmunotherapyRishita Chatterjee, Arturo Simoni-Nieves, An Truong, et al.
Molecular Systems Biology|April 5, 2024
Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stabilityYiQing Lü, Tiffany Cho, Saptaparna Mukherjee, et al.
Clinical Epigenetics|April 29, 2026
GLYATL1 is associated with metabolic and epigenetic changes and with endocrine resistance in luminal breast cancerJanina Müller, Emre Sofyali, Luisa Schwarzmüller, et al.
Nature Metabolism|June 10, 2024
ASS1 metabolically contributes to the nuclear and cytosolic p53-mediated DNA damage responseLisha Qiu Jin Lim, Lital Adler, Emma Hajaj, et al.
Nature Metabolism|July 4, 2024
Author Correction: ASS1 metabolically contributes to the nuclear and cytosolic p53-mediated DNA damage responseLisha Qiu Jin Lim, Lital Adler, Emma Hajaj, et al.
Cancer Discovery|July 27, 2022
AXL and Error-Prone DNA Replication Confer Drug Resistance and Offer Strategies to Treat EGFR-Mutant Lung CancerAshish Noronha, Nishanth Belugali Nataraj, Joo Sang Lee, et al.
Cancer Cell|May 1, 2026
Activated T cell extracellular vesicle DNA transfer enhances antigen presentation and anti-tumor immunityMengying Hu, Di-Ao Liu, Inbal Wortzel, et al.
Nature Medicine|June 28, 2024
Multi-parametric atlas of the pre-metastatic liver for prediction of metastatic outcome in early-stage pancreatic cancerLinda Bojmar, Constantinos P Zambirinis, Jonathan M Hernandez, et al.
Cell|August 16, 2020
Extracellular Vesicle and Particle Biomarkers Define Multiple Human CancersAyuko Hoshino, Han Sang Kim, Linda Bojmar, et al.
Pageof 18